With an effective burden of around 3%, the Cyprus IP Box is among the EU's most attractive regimes for income from intellectual property. But the benefit is tied to a strict framework: the nexus approach. It links the tax relief to the company's own research and development. Neglect the documentation and you risk the benefit.
How the IP Box works
80% of the qualifying profit from qualifying intellectual property is exempt from taxation. At a corporate tax rate of 15%, this produces an effective burden of around 3% on the benefiting income. Cyprus is thus among the lowest EU rates for IP income.
Which IP qualifies – and which does not
Qualifying assets are legally protected rights arising from own development: in particular patents and copyrighted software and comparable rights. Expressly non-qualifying are marketing-related rights, above all trademarks. Anyone planning an IP structure should therefore clarify qualification first.
The nexus approach in detail
The nexus approach (OECD BEPS Action 5) limits the benefiting share to the ratio of own qualifying expenditure to total expenditure. Qualifying expenditure is own R&D and contract research by unrelated third parties; non-qualifying are the acquisition of finished IP and contract research by related parties. A 30% uplift is granted on the qualifying expenditure, capped at total expenditure. Simplified: benefiting profit = total IP profit × (qualifying expenditure × 1.3, at most total expenditure) ÷ total expenditure.
Worked example
A software company earns EUR 1,000,000 profit from self-developed, copyrighted software. Total development expenditure is EUR 500,000, of which EUR 450,000 is own R&D and EUR 50,000 is bought-in services from related parties. The nexus fraction is (450,000 × 1.3 = 585,000, capped at 500,000) ÷ 500,000 = 1.0. The full profit qualifies, 80% is exempt, and on the remaining EUR 200,000 the 15% rate applies – around EUR 30,000, i.e. roughly 3% effective. Were the related-party share higher, the nexus fraction, and with it the benefiting share, would fall.
Documentation is decisive
The nexus approach requires income and expenditure to be allocated per IP asset. Without clean, ongoing documentation of own R&D, contracts and cost allocation, the benefiting share cannot be evidenced – and the benefit is at risk. Documentation therefore belongs in place from the start, not only at tax-return time.
Substance and Pillar Two
The IP Box requires genuine substance: own development, staff and function in Cyprus. The global minimum tax (Pillar Two) affects only very large groups above the EUR 750m revenue threshold; for the vast majority of mid-sized IP structures, the effective burden of around 3% remains fully effective.
The role of CMC: Non-Dom Status
The CMC team structures and documents the IP so that qualification, the nexus fraction and substance are defensible, and coordinates with your German advisor on cross-border effects. Reserved legal acts run through the partner law firm A. Panayiotou LLC.
A worked example
A Cyprus company earns a benefiting profit of EUR 500,000 from self-developed, qualifying software. Through the IP Box, 80% of this profit is exempted from taxation; EUR 100,000 remains taxable. At a corporate tax rate of 15%, the tax is EUR 15,000 – an effective burden of around 3% on the benefiting profit. The condition is that the nexus fraction is fully met, i.e. the development was essentially carried out in-house.
The nexus fraction in detail
The extent of the benefit follows the nexus fraction: it sets the own qualifying development expenditure in relation to the total expenditure for the asset. Own research and development and contract research awarded to unrelated third parties count as qualifying expenditure; the mere acquisition of the intellectual property and awarding it to related parties, by contrast, do not. A limited uplift compensates for small harmful expenditure. The more was developed in-house, the higher the benefiting share – anyone who only buys in loses the advantage.
What qualifies – and what does not
Benefiting are in particular patented inventions and copyright-protected software. Marketing-related intellectual property such as trademarks expressly does not fall under the IP Box. This distinction must be made cleanly in advance and documented on an ongoing basis – ideally per asset, so that qualifying income and expenditure are provable at any time. Without this tracking, the nexus share cannot be evidenced in an audit.
Common Questions about The Cyprus IP Box and the Nexus Approach
What is the effective burden of the IP Box? Around 3%: 80% of the qualifying profit is exempt, the remainder bears 15% corporate tax.
Do trademarks qualify? No. Qualifying are mainly patents and copyrighted software from own development; marketing-related rights such as trademarks are excluded.
What is the nexus approach? It ties the benefiting share to the ratio of own qualifying expenditure to total expenditure, with a 30% uplift.
Does Pillar Two affect me? Only for groups above EUR 750m revenue. For most structures the IP Box remains fully effective.
The IP Box and the Nexus Approach in Detail: The Benefit Earned Through Nexus, Not Assumed from the Rate
The IP Box benefit is earned through the nexus approach—the reduced effective rate applying only to the extent of qualifying R&D expenditure—not assumed from the headline rate for any IP income — the system briefing first: The IP Box has a nexus condition (the IP Box nexus of the nexus sort — the qualifying expenditure ratio of the nexus kinds: the IP Box as the nexus-conditioned benefit; the benefit as the nexus-earned matter, per the IP-Box chapter's law), the nexus ratio limits the benefit (the nexus ratio of the limiting sort — the qualifying-to-total expenditure of the ratio kinds: the nexus ratio of the limiting sort; the benefit of the ratio kind), the benefit is earned through nexus, not assumed from the rate (the IP Box benefit of the earned sort — the rate-assumed of the wrong kinds: the benefit of the earned sort; the IP Box of the earned kind), and the honesty formula opens: The IP Box benefit is earned through the nexus approach—the reduced rate applying to qualifying income in proportion to qualifying R&D expenditure—not assumed from the headline rate for all IP income — the nexus ratio computed, the qualifying expenditure traced, the benefit earned: the IP Box as nexus-earned; whoever assumes the IP Box rate for any IP income assumes away the nexus ratio, and the benefit is earned through nexus, not assumed from the rate. The nexus note of the standing echo: The benefit is nexus-earned (the IP Box nexus of the earned sort — the rate-assumed of the wrong kind: the IP Box benefit earned through nexus, not assumed from the rate, per the IP-Box chapter).
The cross-reference note: The IP-Box, substance and corporate-tax chapters carry the neighbours — this chapter carries the IP Box nexus detail; the library earns its IP Box through nexus.
The Approach in Detail: Nexus, Ratio, Qualifying
The approach briefing of the IP-Box world: The IP Box gives an 80% notional deduction (the 80% notional deduction of the deduction sort — the qualifying-profit relief of the deduction kinds, per the IP-Box chapter: the 80% deduction of the read sort; the IP Box of the deduction kind), the effective rate reads (the effective rate near 2.5% of the rate sort — the best-case rate of the rate kinds, per the IP-Box chapter: the effective rate of the read sort; the IP Box of the rate kind), the nexus approach conditions it (the OECD nexus approach of the nexus sort — the substance-linked benefit of the nexus kinds, per the substance chapter: the nexus approach of the conditioning sort; the IP Box of the nexus kind), the nexus ratio reads (the qualifying expenditure ratio of the ratio sort — the own R&D over total of the ratio kinds: the nexus ratio of the read sort; the IP Box of the ratio kind), the qualifying expenditure reads (the own and outsourced R&D of the qualifying sort — the qualifying versus acquisition of the qualifying kinds: the qualifying expenditure of the read sort; the IP Box of the qualifying kind), the qualifying IP reads (the patents and software of the IP sort — the qualifying IP assets of the qualifying kinds, per the IP-Box chapter: the qualifying IP of the read sort; the IP Box of the IP kind), the DEMPE and substance read (the DEMPE functions of the substance sort — the development substance of the substantive kinds, per the substance chapter: the DEMPE of the read sort; the IP Box of the DEMPE kind), the professional determination reads (the IP Box of the determined sort — the CMC and George Zourides of the mandate kinds: the determination of the professional sort; the IP Box of the advised kind), and the approach formula closes: identify the qualifying IP, trace the qualifying expenditure, compute the nexus ratio, earn the benefit. The IP-Box formula: Qualifying IP profit times nexus ratio times 80% notional deduction equals the nexus-earned benefit — the nexus sentence of the IP Box.
The ratio note of the standing sort: The nexus ratio limits the benefit (the qualifying expenditure ratio of the limiting sort — the rate-assumed of the wrong kind: the nexus ratio limiting the IP Box benefit to qualifying R&D proportion, per the IP-Box chapter).
Practice Lines: Earning the IP Box Through Nexus Right
The practice briefing of the IP world: The qualifying IP is identified (the patents and software of the IP sort — the qualifying assets of the identified kind), the qualifying expenditure is traced (the own and outsourced R&D of the qualifying sort — the qualifying spend of the traced kind), the nexus ratio is computed (the qualifying expenditure ratio of the ratio sort — the own-R&D-over-total of the computed kind), the DEMPE substance is grounded (the DEMPE functions of the substance sort — the development of the grounded kind), the effective rate is calculated (the effective rate of the rate sort — the nexus-adjusted rate of the calculated kind), the determination is professional (the IP Box of the determined sort — the CMC and George Zourides of the mandate kind), and the practice formula closes: identify the qualifying IP, trace the qualifying expenditure, compute the nexus ratio, earn the benefit. The chapter's memory line: The IP Box benefit is earned through the nexus approach—the qualifying IP identified, the qualifying expenditure traced, the nexus ratio computed, the DEMPE substance grounded; those who earn it through nexus claim the true benefit, while assumers of the headline rate assume away the nexus ratio.
The closing classification: The IP Box and the nexus approach give an 80% notional deduction on qualifying IP profit (a best-case effective rate near 2.5%), earned through the OECD nexus approach—the benefit applying in proportion to qualifying R&D expenditure via the nexus ratio, grounded in DEMPE substance—not assumed from the headline rate for any IP income. The CMC team determines the IP Box with George Zourides' accounting lane in every relevant case — the benefit is earned through nexus, not assumed from the rate.
Case Study: The Benefit Earned Through Nexus
The nexus-earned story: an IP company earned the IP Box benefit through the nexus approach rather than assuming the headline rate for all its IP income — the chronicle: The qualifying IP was identified (the patents and software of the IP sort — "I'd heard the Cyprus IP Box gives an effective rate near 2.5% and assumed all my IP income would be taxed at that rate; our advisor corrected this: the benefit is earned through the nexus approach—it applies in proportion to qualifying R&D expenditure, not to all IP income at the headline rate", per the IP-Box chapter), the qualifying expenditure was traced (the own and outsourced R&D of the qualifying sort — "the nexus approach turned on my qualifying expenditure—my own R&D, certain outsourced R&D—versus total expenditure including IP acquisition; tracing this was central"), the nexus ratio was computed (the qualifying expenditure ratio of the ratio sort — "the nexus ratio—qualifying expenditure over total—scaled my benefit; a high ratio (mostly my own R&D) gave most of the benefit, while acquired IP without my R&D reduced it"), the DEMPE substance was grounded (the DEMPE functions of the substance sort — "genuine development substance—the DEMPE functions—grounded it; the benefit follows real development activity", per the substance chapter), the effective rate was calculated (the effective rate of the rate sort — "so my actual effective rate reflected the nexus ratio—near 2.5% only to the extent my qualifying R&D justified it, not automatically on all IP income"), the determination was professional (the IP Box of the determined sort — "George Zourides' accounting lane computed the nexus ratio and the benefit"), and the balance closed earned: identified, traced, computed — the benefit earned through nexus. The company's verdict: "I earned the IP Box benefit through the nexus approach—the qualifying expenditure, the nexus ratio—rather than assuming the headline rate for all IP income; the ones who assume the rate assume away the nexus ratio, and the benefit is earned through nexus, not assumed from the rate."
The lesson of the nexus-earned story: The benefit is earned through nexus — the qualifying IP identified, the expenditure traced and the nexus ratio computed; and earning it through nexus versus assuming the rate is the whole discipline.
Quick FAQ on the IP Box and Nexus Approach
What is the IP Box benefit? An 80% notional deduction on qualifying IP profit — a best-case effective rate near 2.5%. Does the headline rate apply to all IP income? No — the benefit is earned through the nexus approach, in proportion to qualifying R&D expenditure. What's the nexus ratio? Qualifying expenditure over total — it scales the benefit; own R&D qualifies, acquired IP without own R&D reduces it. What's DEMPE? The development, enhancement, maintenance, protection and exploitation functions — the substance grounding the benefit. How is the effective rate found? By calculation — the nexus ratio applied; near 2.5% only to the extent qualifying R&D justifies.
Three Takeaways on the IP Box and Nexus Approach
First: The benefit is earned through nexus — not the headline rate for all IP. Second: The nexus ratio scales it — qualifying R&D over total expenditure. Third: Ground the DEMPE substance — real development activity. Three lines for the IP-Box file.
Glossary of the IP Box Nexus Chapter
IP Box — the qualifying-IP-profit relief (80% notional deduction). Nexus approach — the OECD substance-linked benefit condition. Nexus ratio — the qualifying-expenditure-over-total ratio. Qualifying expenditure — the own and certain outsourced R&D. DEMPE — the development-and-exploitation functions. Five terms for the IP-Box file.
Self-Check: Five Questions on Your IP Box Benefit
The benefit review: Is the qualifying IP identified? Is the qualifying expenditure traced? Is the nexus ratio computed? Is the DEMPE substance grounded? And is the effective rate calculated on the nexus-adjusted basis? Five yeses: the benefit is earned through nexus. Every no risks assuming the headline rate.
Common Misconceptions About the IP Box and Nexus Approach
Three corrections: "The 2.5% rate applies to all IP income" — the benefit is earned through nexus, in proportion to qualifying R&D. "Acquired IP gets the full benefit" — acquired IP without own R&D reduces the nexus ratio. "No substance is needed" — DEMPE development substance grounds the benefit. Three lines for the clear IP-Box view.
The One Sentence on the IP Box and Nexus Approach
For the index card: The IP Box gives an 80% notional deduction on qualifying IP profit (near 2.5% best case), earned through the nexus approach—the benefit scaled by the nexus ratio and grounded in DEMPE substance—not the headline rate for all IP income. One sentence for the IP-Box file.
Further Reading in the IP Box Cluster
The IP Box nexus chapter branches into the IP library: the IP-Box chapters for the deduction, the substance chapters for the DEMPE, the corporate-tax chapter for the rate, the Pillar-Two chapter for the interaction. The cluster message: The IP Box nexus chapter is the nexus desk of the IP library — the benefit earned through nexus; the library earns its IP Box through nexus, not assumed from the rate.
Afterword: The Benefit Is Earned Through Nexus, Not Assumed from the Rate
The closing thought: The company's principle — the benefit is earned through nexus, not assumed from the rate — corrects a headline-rate assumption that the IP Box's attractive number invites, and the correction matters because the near-2.5% rate is what draws attention. The Cyprus IP Box is known for its attractive effective rate—near 2.5% at best, via an 80% notional deduction on qualifying IP profit—and this headline number is what draws companies to it, so it's easy to assume the rate simply applies to IP income, the 2.5% figure standing for what the company will pay on its IP profits; and this headline-rate assumption overstates the benefit by ignoring the nexus approach that conditions it. But the IP Box benefit is earned through the OECD nexus approach: the benefit applies not to all IP income at the headline rate, but in proportion to the company's own qualifying R&D expenditure, via the nexus ratio (qualifying expenditure over total expenditure)—so a company that developed its IP through its own R&D (high nexus ratio) gets most of the benefit, while a company that acquired IP without its own R&D (low nexus ratio) gets much less, the benefit scaled to the company's substantive contribution rather than granted at the headline rate regardless. The earn-through-nexus discipline computes the actual benefit: the qualifying IP identified, the qualifying expenditure traced (own R&D, certain outsourced R&D, versus acquisition costs), the nexus ratio computed, the DEMPE substance grounded (genuine development activity), the effective rate calculated on this basis—the benefit earned in proportion to qualifying R&D rather than assumed from the headline rate. And the nexus ratio embodies a policy principle the headline-rate assumption misses: the OECD nexus approach ties IP tax benefits to substantive R&D activity (to prevent IP regimes from being mere rate arbitrage detached from real innovation), so the benefit is deliberately linked to the company's own development effort—meaning the IP Box rewards genuine R&D-driven IP, not IP income as such, and the headline rate is available only to the extent the company's qualifying R&D justifies it. This is the library's calculate-don't-quote and substance-earns-the-benefit principles applied to the IP Box: the same discipline that calculates the IP Box's effective rate rather than quoting the headline and earns the NID on new equity, here earning the IP Box through the nexus ratio. So earn the IP Box benefit through the nexus approach—tracing the qualifying expenditure and computing the nexus ratio—rather than assuming the headline rate for all IP income. The near-2.5% rate draws attention, which invites assuming it applies to all IP income—but the benefit is earned through nexus, scaled by qualifying R&D and grounded in DEMPE substance, and it's earned through nexus, not assumed from the rate, so the company that computes the nexus ratio knows its true benefit, while the one that assumes the headline rate overstates a benefit that the nexus approach, tying it to genuine R&D, actually confines to the company's own substantive contribution.
Related Articles
Individual Consultation
This article is for general guidance and does not replace individual advice. Every case has its specifics – the type of income, personal circumstances, tax history and long-term objectives all significantly influence the optimal structure.
The CMC team structures and documents your IP so the nexus benefit is defensible. Book a free initial consultation: Book appointment · kontakt@steuerberater-zypern.info · WhatsApp +357 95 140797
💬